MYSZ Fundamental Analysis - MY SIZE INC

Fundamental Rating

MYSZ gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 280 industry peers in the Software industry. MYSZ has a bad profitability rating. Also its financial health evaluation is rather negative. MYSZ is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

MYSZ had negative earnings in the past year.

In the past year MYSZ has reported a negative cash flow from operations.

MYSZ had negative earnings in each of the past 5 years.

In the past 5 years MYSZ always reported negative operating cash flow.

1.2 Ratios

MYSZ has a worse Return On Assets (-30.55%) than 77.14% of its industry peers.

Looking at the Return On Equity, with a value of -48.79%, MYSZ is doing worse than 69.29% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-30.55%
ROE	-48.79%
ROIC	N/A

ROA(3y)-65.37%

ROA(5y)-90.51%

ROE(3y)-125.25%

ROE(5y)-153.85%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

MYSZ has a Gross Margin of 38.67%. This is in the lower half of the industry: MYSZ underperforms 77.14% of its industry peers.

In the last couple of years the Gross Margin of MYSZ has declined.

The Profit Margin and Operating Margin are not available for MYSZ so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	38.67%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-26.17%

GM growth 5Y-9.6%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MYSZ does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, MYSZ has more shares outstanding

MYSZ has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, MYSZ has an improved debt to assets ratio.

2.2 Solvency

MYSZ has an Altman-Z score of -7.30. This is a bad value and indicates that MYSZ is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -7.30, MYSZ is doing worse than 86.79% of the companies in the same industry.

MYSZ has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.

MYSZ has a Debt to Equity ratio of 0.13. This is comparable to the rest of the industry: MYSZ outperforms 51.79% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.13
Debt/FCF	N/A
Altman-Z	-7.3

ROIC/WACCN/A

WACC9.46%

2.3 Liquidity

MYSZ has a Current Ratio of 2.73. This indicates that MYSZ is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 2.73, MYSZ is in the better half of the industry, outperforming 73.21% of the companies in the same industry.

MYSZ has a Quick Ratio of 1.72. This is a normal value and indicates that MYSZ is financially healthy and should not expect problems in meeting its short term obligations.

The Quick ratio of MYSZ (1.72) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	2.73
Quick Ratio	1.72

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

MYSZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.94%, which is quite impressive.

Looking at the last year, MYSZ shows a very negative growth in Revenue. The Revenue has decreased by -22.01% in the last year.

The Revenue has been growing by 165.15% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)78.94%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%67.76%

Revenue 1Y (TTM)-22.01%

Revenue growth 3Y297.97%

Revenue growth 5Y165.15%

Sales Q2Q%39.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y33.17%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year12.88%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

MYSZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MYSZ. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

MYSZ does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

MY SIZE INC

NASDAQ:MYSZ (12/12/2025, 8:00:01 PM)

After market: 0.92 0 (0%)

0.92

-0.01 (-1.34%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)03-27 2025-03-27/amc

Earnings (Next)N/A N/A

Inst Owners3.26%

Inst Owner Change78.15%

Ins Owners3.05%

Ins Owner Change0.92%

Market Cap3.54M

Revenue(TTM)7.51M

Net Income(TTM)-3.56M

Analysts82.86

Price Target3.06 (232.61%)

Short Float %5.24%

Short Ratio2.36

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.47
P/FCF	N/A
P/OCF	N/A
P/B	0.49
P/tB	0.73
EV/EBITDA	N/A

EPS(TTM)-1.6

EYN/A

EPS(NY)-2.75

Fwd EYN/A

FCF(TTM)-0.88

FCFYN/A

OCF(TTM)-0.88

OCFYN/A

SpS1.95

BVpS1.9

TBVpS1.26

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-30.55%
ROE	-48.79%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	38.67%
FCFM	N/A

ROA(3y)-65.37%

ROA(5y)-90.51%

ROE(3y)-125.25%

ROE(5y)-153.85%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-26.17%

GM growth 5Y-9.6%

F-Score3

Asset Turnover0.64

Health

		Industry Rank	Sector Rank
Debt/Equity	0.13
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.73
Quick Ratio	1.72
Altman-Z	-7.3

F-Score3

WACC9.46%

ROIC/WACCN/A

Cap/Depr(3y)6.12%

Cap/Depr(5y)22.62%

Cap/Sales(3y)0.26%

Cap/Sales(5y)5.92%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)78.94%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%67.76%

EPS Next Y33.17%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-22.01%

Revenue growth 3Y297.97%

Revenue growth 5Y165.15%

Sales Q2Q%39.86%

Revenue Next Year12.88%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-0.08%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y46.42%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y46.78%

OCF growth 3YN/A

OCF growth 5YN/A

MY SIZE INC / MYSZ FAQ

What is the fundamental rating for MYSZ stock?

ChartMill assigns a fundamental rating of 2 / 10 to MYSZ.

Can you provide the valuation status for MY SIZE INC?

ChartMill assigns a valuation rating of 0 / 10 to MY SIZE INC (MYSZ). This can be considered as Overvalued.

Can you provide the profitability details for MY SIZE INC?

MY SIZE INC (MYSZ) has a profitability rating of 0 / 10.

What is the expected EPS growth for MY SIZE INC (MYSZ) stock?

The Earnings per Share (EPS) of MY SIZE INC (MYSZ) is expected to grow by 33.17% in the next year.

MY SIZE INC (MYSZ) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

MY SIZE INC / MYSZ FAQ

What is the fundamental rating for MYSZ stock?

Can you provide the valuation status for MY SIZE INC?

Can you provide the profitability details for MY SIZE INC?

What is the expected EPS growth for MY SIZE INC (MYSZ) stock?